Market Tracker

02/24 5:16pm ET

Mast Therapeutics Inc (NYSE MKT LLC:MSTX)

0.12
Delayed Data
As of Feb 24
 -0.0031 / -2.52%
Today’s Change
0.07
Today|||52-Week Range
0.71
+38.25%
Year-to-Date
No recent news for Mast Therapeutics Inc.

Today’s Trading

Previous close0.12
Today’s open0.12
Day’s range0.12 - 0.12
Volume4,980,947
Average volume (3 months)8,256,001
Market cap$28.6M
Dividend yield--
Data as of 4:02pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-8.70%
Earnings growth (this year)+20.00%
Earnings growth (next 5 years)+57.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.82

Competitors

 Today’s
change
Today’s
% change
ANTHAnthera Pharmaceutic...+0.00+0.58%
PPHMPPeregrine Pharmaceut...-0.30-1.60%
EYEGEyeGate Pharmaceutic...+0.04+1.42%
NVGNNovogen Ltd+0.02+1.18%
Data as of 4:00pm ET, 02/24/2017

Financials

Next reporting dateMarch 21, 2017
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$0.00
Annual profit (last year)-$39.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Brian M. Culley
CFO, Principal Accounting Officer &
SVP
Brandi L. Roberts
Corporate headquarters
San Diego, California

Forecasts